Buprenorphine

Opioid Use Disorder

Buprenorphine is frequently used to treat addiction to opioid drugs, such as heroin or prescription pain medications. It helps by reducing withdrawal symptoms and decreasing the craving for other opioids. When used for this purpose, it is typically part of a comprehensive treatment plan that includes counseling and behavioral therapy.

Chronic Pain Management

Certain forms of buprenorphine, such as skin patches or films applied to the inside of the cheek, are used to manage pain that is severe enough to require daily, long-term treatment. This use is generally reserved for situations where other non-opioid or immediate-release opioid medications do not provide enough relief or cannot be tolerated. These long-acting forms are not intended for use on an as-needed basis for mild pain.

Moderate to Severe Pain

Injectable versions of the medication may be used in medical settings to treat moderate to severe pain. These are typically administered by healthcare professionals for short-term pain relief when other treatments are not appropriate.

How Buprenorphine Affects the Body

Buprenorphine belongs to a class of medications called opioid partial agonists. It works by binding to the same receptors in the brain that are affected by other opioids, such as heroin or prescription pain medications. However, because it is a partial agonist, it produces weaker effects than full opioids.

Managing Opioid Use Disorder

When used to treat opioid use disorder, buprenorphine helps in the following ways:

• Reducing Cravings: By occupying the brain's opioid receptors, it satisfies the body's physical need for opioids without producing a significant high.
• Preventing Withdrawal: It helps stabilize the brain chemistry, which prevents the physical symptoms of withdrawal.
• Blocking Other Opioids: Because it sticks strongly to the receptors, it can block other opioids from attaching, making them less effective if they are used.

Pain Relief

For chronic or severe pain, buprenorphine works by changing how the central nervous system and the brain respond to pain signals. It provides long-lasting relief by continuously stimulating the receptors at a level sufficient to dull pain sensations.

The Ceiling Effect

One unique feature of buprenorphine is its ceiling effect. This means that after a certain dose, the effects of the drug—such as the feeling of euphoria or the slowing of breathing—do not increase further. This characteristic helps lower the risk of misuse and overdose compared to full opioid medications.

Common Side Effects

Many people using buprenorphine experience mild side effects. These may include:

• Constipation, nausea, or vomiting
• Headache
• Dizziness or lightheadedness
• Drowsiness or fatigue
• Increased sweating
• Dry mouth
• Difficulty falling asleep or staying asleep
• Blurred vision

If you use the skin patch or oral film, you may also experience redness, itching, or irritation at the site of application.

Serious Side Effects

Seek immediate medical attention if you experience any of the following serious symptoms:

• Slowed, shallow, or difficult breathing
• Extreme drowsiness or feeling like you might pass out
• Signs of an allergic reaction, such as hives, rash, or swelling of the face, lips, or throat
• Liver problems, including yellowing of the skin or eyes, dark urine, or pain in the upper right stomach area
• Adrenal insufficiency, which may cause nausea, vomiting, loss of appetite, or unusual weakness
• Confusion, hallucinations, or rapid heartbeat

Buprenorphine products that dissolve in the mouth have been associated with dental problems, including cavities, tooth decay, and gum infections. It is important to notify your dentist that you are taking this medication.

If you stop taking buprenorphine suddenly, you may experience withdrawal symptoms such as body aches, diarrhea, or irritability. Do not stop this medication without consulting a healthcare provider.

Boxed Warnings

Buprenorphine carries several serious warnings, including:

• Addiction and Misuse: There is a risk of opioid use disorder, which can lead to overdose and death.
• Respiratory Depression: Life-threatening breathing problems may occur, especially during the start of treatment or following a dose increase.
• Accidental Ingestion: Even a single dose can be fatal to children who accidentally ingest the medication.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can cause life-threatening withdrawal symptoms in the newborn.

Respiratory and Central Nervous System Risks

Combining buprenorphine with alcohol, benzodiazepines, or other central nervous system depressants increases the risk of profound sedation, respiratory distress, coma, and death. While these combinations are risky, healthcare providers are advised to manage these risks rather than automatically withholding treatment for opioid use disorder.

Dental Complications

Medications dissolved in the mouth (sublingual or buccal) have been linked to serious dental problems. These include tooth decay, cavities, oral infections, and tooth loss, even in patients with no prior history of dental issues.

Other Precautions

• Liver Health: Cases of moderate to severe liver injury have been reported. Liver function monitoring is often recommended during treatment.
• Adrenal Insufficiency: Long-term opioid use may cause the adrenal glands to stop producing enough cortisol, leading to symptoms like nausea, dizziness, and fatigue.
• Serotonin Syndrome: A potentially life-threatening condition may occur if buprenorphine is used with certain antidepressants or other drugs that affect serotonin levels.
• Sleep-Related Breathing Disorders: Buprenorphine can cause or worsen sleep apnea and other breathing issues during sleep.
• Low Blood Pressure: This medication may cause a significant drop in blood pressure, which can lead to dizziness or fainting when standing up too quickly.

Pregnancy

Using buprenorphine during pregnancy can lead to neonatal opioid withdrawal syndrome. This is a condition where the baby experiences withdrawal symptoms after birth because of exposure to the medication in the womb. This condition can be life-threatening if it is not identified and treated by medical professionals.

Symptoms of withdrawal in a newborn may include:

• Irritability and high-pitched crying
• Tremors or shaking
• Abnormal sleep patterns
• Vomiting or diarrhea
• Failure to gain weight

If you are pregnant or planning to become pregnant, talk to your doctor about the risks and benefits of treatment. Do not stop taking buprenorphine suddenly without medical guidance, as this can cause serious problems for both the parent and the fetus.

Breastfeeding

Buprenorphine passes into breast milk in small amounts. While breastfeeding is often possible for those on stable treatment, the infant must be monitored closely for side effects.

Seek medical attention immediately if a nursing infant shows signs of:

• Excessive sleepiness or difficulty waking up
• Difficulty breathing or slow breathing
• Limpness

The decision to breastfeed while taking buprenorphine should be made in consultation with a healthcare professional to weigh the benefits of breastfeeding against the potential risks to the baby.

Oral and Mucosal Forms

These forms are designed to be absorbed through the lining of the mouth rather than swallowed. Swallowing these medications may prevent them from working correctly.

• Sublingual tablets: These are placed under the tongue to dissolve completely.
• Sublingual films: These are thin strips placed under the tongue.
• Buccal films: These are thin strips placed against the inside of the cheek to dissolve.

Transdermal Forms

Buprenorphine is available as a transdermal patch. This patch is applied to the skin and releases the medication continuously over a period of several days.

Injectable and Implantable Forms

These versions are typically administered by a healthcare professional in a medical setting:

• Injectable solutions: These may be given into a muscle or a vein for immediate or short-term use.
• Extended-release injections: These are administered under the skin (subcutaneously) to provide medication over a longer period, such as once a month.
• Subdermal implants: These consist of small rods inserted under the skin of the upper arm. They provide a continuous dose of medication for several months.

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) has approved buprenorphine for two primary purposes: the treatment of opioid use disorder (OUD) and the management of pain severe enough to require daily, long-term opioid treatment when other options are inadequate. For OUD, it may be used alone or in combination with naloxone.

Controlled Substance Status

Buprenorphine is a Schedule III controlled substance. This classification indicates that while it has a recognized medical use, it also carries a potential for abuse and may lead to moderate or low physical dependence or high psychological dependence.

Safety Communications and Warnings

The FDA has issued several important safety communications regarding buprenorphine:

• Dental Health: In 2022, the FDA warned that buprenorphine medicines dissolved in the mouth (sublingual or buccal) have been linked to serious dental problems, including tooth decay, cavities, and oral infections, even in patients with no prior history of dental issues.
• Combined Use with Other Sedatives: The FDA urges healthcare providers to exercise caution but generally not to withhold buprenorphine from patients taking benzodiazepines or other central nervous system depressants, as the risk of untreated opioid addiction often outweighs the risks of combined use.

Risk Evaluation and Mitigation Strategy (REMS)

To manage the risks of respiratory depression, accidental exposure, and misuse, certain buprenorphine products are required to have a Risk Evaluation and Mitigation Strategy (REMS). These programs are designed to ensure that the benefits of the medication outweigh its risks through provider education and specific distribution requirements.

Understanding Buprenorphine Withdrawal

Buprenorphine is an opioid medication that can cause physical dependence when used regularly. If you stop taking it abruptly or reduce your dose too quickly, you may experience withdrawal symptoms.

Common Withdrawal Symptoms

Withdrawal symptoms can range from mild to severe and may include:

• Nausea, vomiting, or diarrhea
• Muscle aches, backache, or joint pain
• Restlessness, irritability, or anxiety
• Sleep problems (insomnia)
• Sweating, chills, or goosebumps
• Runny nose or watery eyes
• Dilated pupils
• Increased heart rate or blood pressure

Safe Discontinuation

To avoid or minimize withdrawal symptoms, do not stop taking buprenorphine without consulting a healthcare provider. Doctors typically recommend a gradual tapering process, where the dose is slowly reduced over time.

Precipitated Withdrawal

Buprenorphine can also cause precipitated withdrawal if it is started while other full-agonist opioids are still active in your system. This results in the sudden and intense onset of withdrawal symptoms. Healthcare providers usually wait until you are in the early stages of withdrawal from other opioids before starting the first dose of buprenorphine.